WANG LAI (Global Head of R&D) sold 1.17K shares of BEONE MEDICINES LTD. on the open market
Open‑market sale worth $310.2K. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/18/2026ACC: 0001852291-26-000006
Officer· Global Head of R&D
Since Apr 2021
-1.17K
Net shares
Net seller
$310.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.17K disposed
Non-Derivative Transactions1
American Depositary Shares
Direct
Shares
−1.17K
Price / share
$265.39
Trade value
$310.24K
% of position
New position
6/16/2026
1.17K→0.00
Total
Net shares
−1.17K
Net value
-$310.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| American Depositary Shares Direct | 6/16/2026 | S · Sale | −1.17K | $265.39 | $310.24K | New position | 1.17K | 0.00 |
| Total | −1.17K | -$310.24K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)3
Ordinary Shares
DirectShares owned1.69M
Ordinary Shares
IndirectShares owned601.97K
RMB Shares
IndirectShares owned0.00
Total
1.69M direct·601.97K indirect2.30M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 1.69M | Direct |
| Ordinary Shares | 601.97K | Indirect |
| RMB Shares | 0.00 | Indirect |
| Total | 2.30M | 1.69M direct·601.97K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported